Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma

Concomitant deregulation of MYC and BCL2 comprises clinically significant, yet poorly characterized biological high-risk feature in diffuse large B-cell lymphoma (DLBCL). To interrogate these lymphomas, we analyzed translocations and protein expression of BCL2, BCL6, and MYC; correlated the findings...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Meriranta, Leo, Pasanen, Annika, Alkodsi, Amjad, Haukka, Jari, Karjalainen-Lindsberg, Marja-Liisa, Leppä, Sirpa
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Lymphoid Neoplasia
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422114/
https://ncbi.nlm.nih.gov/pubmed/32780847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001727
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料